Development of De Novo Donor-specific HLA Antibodies and AMR in Renal Transplant Patients Depends on CYP3A5 Genotype.

Transplantation · 2022 · PMC9038248 · PMID 34241984

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

showed a trendno p-value reported

The results for de novo class II DSAs showed a trend but failed to reach statistical significance (Table 2 and Figure S2B, SDC , http://links.lww.com/TP/C259 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.